Standout Papers

Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation 2023 2026 202497
  1. Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation (2023)
    Stephen J. Nicholls, Steven E. Nissen et al. JAMA

Immediate Impact

1 by Nobel laureates 5 from Science/Nature 62 standout
Sub-graph 1 of 20

Citing Papers

Global Effect of Cardiovascular Risk Factors on Lifetime Estimates
2025 Standout
Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
2025 Standout
1 intermediate paper

Works of P. Kellie Turner being referenced

Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation
2023 Standout

Author Peers

Author Last Decade Papers Cites
P. Kellie Turner 370 377 156 156 43 787
T. Cerny 344 152 108 237 36 874
Xuan Zheng 167 161 101 144 46 731
Jacob Colsky 448 174 63 235 40 892
Meera Tugnait 297 309 102 337 24 884
Davide Lombardi 593 301 68 200 57 968
Yasuhito Fujisaka 474 270 59 244 50 871
Basile Chrétien 510 199 65 104 43 871
S. Matthews 284 213 46 265 39 719
T Horie 241 157 40 83 34 783
Diana Stempak 251 199 177 379 22 961

All Works

Loading papers...

Rankless by CCL
2026